3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like <b>GE Ventures</b>, <b>Mayo Clinic Ventures</b> And <b>DFJ</b> Invest $13.75 Million In First Software Platform To Accelerate Cancer Cure Process And Delivery June 19, 2017 Hebron Technology Co. Signs Framework Agreement To Form JV With Ukrainian Company June 25, 2017 AstraZeneca PLC Forges $400 Million Parkinson's R&D Deal With Takeda August 28, 2017
<b>GE Ventures</b>, <b>Mayo Clinic Ventures</b> And <b>DFJ</b> Invest $13.75 Million In First Software Platform To Accelerate Cancer Cure Process And Delivery June 19, 2017
